Reporting owner · CIK 0001810406

Bjork Elisabeth

SEC Form 4 history for the last 180 days across 1 company, 8 transactions and 2 filings.

DIRPharvaris N.V.
Open-market transaction mix0% buys0 buys · 2 sales

Period: Last 180 days

Trade dates in this period: May 20, 2026 – Sep 17, 2026

Transaction history, summary figures and purchase returns cover the last 180 days. Earlier activity is excluded from those sections.

Filings2Form 4 records
Buying$00 purchases
Selling$2.28M2 sales
Net value−$2.28MBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from the last 180 days.
Bjork Elisabeth transactions · 20 per page
CompanyActivityDisclosed valueFiled (ET)
PHVSPharvaris N.V.
Director
DIR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Derivative securitySEC filing ↗
$0View disclosure →
PHVSPharvaris N.V.
Director
DIR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Derivative securitySEC filing ↗
$0View disclosure →
PHVSPharvaris N.V.
Director
DIR
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$1.99MView disclosure →
PHVSPharvaris N.V.
Director
DIR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
SEC filing ↗
$317kView disclosure →
PHVSPharvaris N.V.
Director
DIR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
SEC filing ↗
$504kView disclosure →
PHVSPharvaris N.V.
Director
DIR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
Derivative securitySEC filing ↗
$0View disclosure →
PHVSPharvaris N.V.
Director
DIR
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
−$293kView disclosure →
PHVSPharvaris N.V.
Director
DIR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
$80.5kView disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

The insider reported a sale at Pharvaris N.V. on Sep 17, 2026 valued at $1,989,408.75.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Monthly open-market activity

Last 2 reported months · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
May 202601$0$293,166−$293,166
Sep 202601$0$1,989,408.75−$1,989,408.75

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$1.14M
Median P/S size$1.14M
Direct8
Indirect0
Sep 17, 2026exercise

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
No open-market purchases in the last 180 days

A 90-day purchase return requires an open-market buy. None is recorded in the last 180 days. Purchases filed earlier are outside the visible history and are not included.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

5 observations · May 20, 2026 – Sep 17, 2026. Window ends at the latest available report, not today.

Selected observation · Sep 17, 202615,167 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
May 20, 202625,167May 22, 2026View transaction
May 20, 202615,167May 22, 2026View transaction
Sep 17, 202650,167Sep 21, 2026View transaction
Sep 17, 202667,667Sep 21, 2026View transaction
Sep 17, 202615,167Sep 21, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Bjork Elisabeth Insider Activity FAQ

SEC Form 4 context

Who is Bjork Elisabeth?

Bjork Elisabeth is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001810406.

Which companies has Bjork Elisabeth reported transactions for?

Pharvaris N.V., ROCKET PHARMACEUTICALS, INC.

When was Bjork Elisabeth's latest insider buy?

No open-market insider purchase is recorded in the last 180 days. Earlier filings are outside the visible history.

When was Bjork Elisabeth's latest insider sale?

The insider reported a sale at Pharvaris N.V. on Sep 17, 2026 valued at $1,989,408.75.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.